Long-Term Benzodiazepine Use in Patients With Major Depressive Disorder in China: Long-Term Benzodiazepine Use in Patients With Major Depressive Disorder in China

tianmei si,keqing li,qiyi mei,xiansheng chen,jianguo shi,l sun,xiehe liu,peishen bai,gaohua wang,cui ma,helen f k chiu,gabor s ungvari,amy m kilbourne,xin yu,liang shu,yunai su,yutao xiang,youhong li

DOI: https://doi.org/10.1111/ppc.12035

2013-01-01

Perspectives In Psychiatric Care

Abstract:PURPOSE: There have been no data about long-term benzodiazepine (BZD) use and its correlates in patients with major depressive disorder (MDD) in China. This study aimed to examine the prevalence of long-term BZD use (more than three months) and its demographic and clinical correlates in Chinese patients with MDD. DESIGN AND METHODS: A total of 1,192 patients with MDD were examined in 10 mental health centers in China. Patients' socio-demographic and clinical characteristics and prescriptions for psychotropic drugs were recorded using a standardized form. FINDINGS: A large portion of patients (36.2%) received long-term BZD treatment. Univariate analyses revealed that long-term BZD users were older, poorer, and had more impaired occupational functioning than patients not taking BZDs. Long-term BZD users had fewer psychotic symptoms and took less antipsychotic drugs. In multivariate analyses, long-term BZD use was independently associated with older age and more severe impaired occupational functioning; long-term BZD users were less likely to receive antipsychotic medications and traditional antidepressants (tricyclic antidepressants, tetracyclic antidepressant, and monoamine oxidase inhibitors). PRACTICE IMPLICATIONS: Long-term BZD use was common in patients with MDD in China. A host of demographic and clinical factors were independently associated with long-term BZD use.